New York S01862 amends the general business law to ensure proper packaging and labeling of pharmaceutical drugs and imposes penalties for fraudulent.
New York S01862 introduces stricter regulations on the packaging and labeling of pharmaceutical drugs. The bill aims to prevent intentional fraudulent replacement, packaging, and labeling of drugs, enhancing consumer protection. It defines terms such as "sell," "remove," and "conceal" to clarify the scope of the law. Violations are subject to misdemeanor charges, and the court may issue injunctions and impose civil penalties. The bill also allows the attorney general to seek preliminary relief without prior notice if deemed not in the public interest.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.